Technical Analysis for ADCT - ADC Therapeutics SA
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Gapped Up | Strength | 0.00% | |
Down 3 Days in a Row | Weakness | 4.61% | |
20 DMA Resistance | Bearish | 0.00% | |
50 DMA Resistance | Bearish | 0.00% | |
20 DMA Resistance | Bearish | -1.99% | |
Fell Below 50 DMA | Bearish | -1.99% | |
20 DMA Resistance | Bearish | -3.59% | |
Crossed Above 50 DMA | Bullish | -3.59% | |
Gapped Up | Strength | -3.59% | |
20 DMA Resistance | Bearish | 0.00% |
Alert | Time |
---|---|
Up 3% | about 19 hours ago |
Possible NR7 | about 19 hours ago |
Possible Inside Day | about 19 hours ago |
60 Minute Opening Range Breakout | about 23 hours ago |
Gap Up Partially Closed | about 23 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/04/2024
ADC Therapeutics SA is a clinical-stage biotechnology company, which develops antibody drug conjugates. Its products include Lonca, Cami and ADCT-602. Its drugs are used in treating various advanced solid tumors. The company was founded on June 6, 2011 and is headquartered in Epalinges, Switzerland.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Solid Tumors Drugs Monoclonal Antibodies Advanced Solid Tumors Antibody Drug Conjugate Lonca Synaffix
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Solid Tumors Drugs Monoclonal Antibodies Advanced Solid Tumors Antibody Drug Conjugate Lonca Synaffix
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 6.04 |
52 Week Low | 0.3599 |
Average Volume | 342,529 |
200-Day Moving Average | 3.64 |
50-Day Moving Average | 3.02 |
20-Day Moving Average | 3.03 |
10-Day Moving Average | 2.99 |
Average True Range | 0.18 |
RSI (14) | 47.37 |
ADX | 9.31 |
+DI | 18.13 |
-DI | 22.71 |
Chandelier Exit (Long, 3 ATRs) | 2.91 |
Chandelier Exit (Short, 3 ATRs) | 3.24 |
Upper Bollinger Bands | 3.30 |
Lower Bollinger Band | 2.75 |
Percent B (%b) | 0.36 |
BandWidth | 18.25 |
MACD Line | -0.03 |
MACD Signal Line | -0.01 |
MACD Histogram | -0.0198 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.14 | ||||
Resistance 3 (R3) | 3.12 | 3.03 | 3.11 | ||
Resistance 2 (R2) | 3.03 | 2.99 | 3.04 | 3.10 | |
Resistance 1 (R1) | 2.99 | 2.96 | 3.01 | 3.01 | 3.09 |
Pivot Point | 2.91 | 2.91 | 2.92 | 2.92 | 2.91 |
Support 1 (S1) | 2.87 | 2.86 | 2.89 | 2.89 | 2.81 |
Support 2 (S2) | 2.78 | 2.83 | 2.79 | 2.80 | |
Support 3 (S3) | 2.74 | 2.78 | 2.79 | ||
Support 4 (S4) | 2.76 |